Document Detail


Lost in translation: the unintended consequences of advance directive law on clinical care.
MedLine Citation:
PMID:  21242368     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Advance directive law may compromise the clinical effectiveness of advance directives.
PURPOSE: To identify unintended legal consequences of advance directive law that may prevent patients from communicating end-of-life preferences.
DATA SOURCES: Advance directive legal statutes for all 50 U.S. states and the District of Columbia and English-language searches of LexisNexis, Westlaw, and MEDLINE from 1966 to August 2010.
STUDY SELECTION: Two independent reviewers selected 51 advance directive statutes and 20 articles. Three independent legal reviewers selected 105 legal proceedings.
DATA EXTRACTION: Two reviewers independently assessed data sources and used critical content analysis to determine legal barriers to the clinical effectiveness of advance directives. Disagreements were resolved by consensus.
DATA SYNTHESIS: Legal and content-related barriers included poor readability (that is, laws in all states were written above a 12th-grade reading level), health care agent or surrogate restrictions (for example, 40 states did not include same-sex or domestic partners as default surrogates), and execution requirements needed to make forms legally valid (for example, 35 states did not allow oral advance directives, and 48 states required witness signatures, a notary public, or both). Vulnerable populations most likely to be affected by these barriers included patients with limited literacy, limited English proficiency, or both who cannot read or execute advance directives; same-sex or domestic partners who may be without legally valid and trusted surrogates; and unbefriended, institutionalized, or homeless patients who may be without witnesses and suitable surrogates.
LIMITATION: Only appellate-level legal cases were available, which may have excluded relevant cases.
CONCLUSION: Unintended negative consequences of advance directive legal restrictions may prevent all patients, and particularly vulnerable patients, from making and communicating their end-of-life wishes and having them honored. These restrictions have rendered advance directives less clinically useful. Recommendations include improving readability, allowing oral advance directives, and eliminating witness or notary requirements.
PRIMARY FUNDING SOURCE: U.S. Department of Veterans Affairs and the Pfizer Foundation.
Authors:
Lesley S Castillo; Brie A Williams; Sarah M Hooper; Charles P Sabatino; Lois A Weithorn; Rebecca L Sudore
Related Documents :
20568098 - Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based app...
20889208 - Swedish legal scholarship concerning protection of vulnerable groups: therapeutic and p...
21500988 - Barrels xxiii: barrels by the shore.
17717558 - We are the daily bread of each other.
1573648 - Rosencrantz and guildenstern are 'dead'?
16114278 - Diagnostic and therapeutic consensus on acromegaly.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  Annals of internal medicine     Volume:  154     ISSN:  1539-3704     ISO Abbreviation:  Ann. Intern. Med.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-18     Completed Date:  2011-02-23     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  0372351     Medline TA:  Ann Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  121-8     Citation Subset:  AIM; IM    
Affiliation:
University of California, San Francisco, San Francisco Veterans Affairs Medical Center, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Advance Directives / legislation & jurisprudence*
Communication Barriers*
Cultural Diversity
Homosexuality
Humans
Patient Rights*
Religion
Social Isolation
Spouses
United States
Grant Support
ID/Acronym/Agency:
K23 AG033102-03/AG/NIA NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Addressing missing data in clinical trials.
Next Document:  Development of a photographic scale for consistency and guidance in dermatologic assessment of forea...